[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CRO in Clinical Trials Industry Research Report 2023

August 2023 | 84 pages | ID: CD97F00CF360EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights

The global CRO in Clinical Trials market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

North American market for CRO in Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Asia-Pacific market for CRO in Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

The major global companies of CRO in Clinical Trials include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

The global market for CRO in Clinical Trials in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Phase I Trial, which accounted for % of the global market of CRO in Clinical Trials in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for CRO in Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRO in Clinical Trials.

The CRO in Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global CRO in Clinical Trials market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRO in Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Labcorp
  • IQVIA
  • Parexel
  • Syneos Health
  • PRA Health Sciences
  • PPD
  • ICON
  • MedPace
  • Wuxi AppTec
Product Type Insights

Global markets are presented by CRO in Clinical Trials type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the CRO in Clinical Trials are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

CRO in Clinical Trials segment by Type
  • Phase I Trial
  • Phase II Trial
  • Phase III Trial
  • Phase IV Trial
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the CRO in Clinical Trials market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the CRO in Clinical Trials market.

CRO in Clinical Trials Segment by End User
  • Pharmaceutical
  • Bio-pharm
  • Others
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the CRO in Clinical Trials market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO in Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of CRO in Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the CRO in Clinical Trials industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO in Clinical Trials.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of CRO in Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 CRO in Clinical Trials by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
  1.2.2 Phase I Trial
  1.2.3 Phase II Trial
  1.2.4 Phase III Trial
  1.2.5 Phase IV Trial
2.3 CRO in Clinical Trials by End User
  2.3.1 Market Value Comparison by End User (2018 VS 2022 VS 2029)
  2.3.2 Pharmaceutical
  2.3.3 Bio-pharm
  2.3.4 Others
2.4 Assumptions and Limitations

3 CRO IN CLINICAL TRIALS BREAKDOWN DATA BY TYPE

3.1 Global CRO in Clinical Trials Historic Market Size by Type (2018-2023)
3.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2023-2028)

4 CRO IN CLINICAL TRIALS BREAKDOWN DATA BY END USER

4.1 Global CRO in Clinical Trials Historic Market Size by End User (2018-2023)
4.2 Global CRO in Clinical Trials Forecasted Market Size by End User (2018-2023)

5 GLOBAL GROWTH TRENDS

5.1 Global CRO in Clinical Trials Market Perspective (2018-2029)
5.2 Global CRO in Clinical Trials Growth Trends by Region
  5.2.1 Global CRO in Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
  5.2.2 CRO in Clinical Trials Historic Market Size by Region (2018-2023)
  5.2.3 CRO in Clinical Trials Forecasted Market Size by Region (2024-2029)
5.3 CRO in Clinical Trials Market Dynamics
  5.3.1 CRO in Clinical Trials Industry Trends
  5.3.2 CRO in Clinical Trials Market Drivers
  5.3.3 CRO in Clinical Trials Market Challenges
  5.3.4 CRO in Clinical Trials Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top CRO in Clinical Trials Players by Revenue
  6.1.1 Global Top CRO in Clinical Trials Players by Revenue (2018-2023)
  6.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2018-2023)
6.2 Global CRO in Clinical Trials Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of CRO in Clinical Trials Head office and Area Served
6.4 Global CRO in Clinical Trials Players, Product Type & Application
6.5 Global CRO in Clinical Trials Players, Date of Enter into This Industry
6.6 Global CRO in Clinical Trials Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America CRO in Clinical Trials Market Size (2018-2029)
7.2 North America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America CRO in Clinical Trials Market Size by Country (2018-2023)
7.4 North America CRO in Clinical Trials Market Size by Country (2024-2029)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe CRO in Clinical Trials Market Size (2018-2029)
8.2 Europe CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe CRO in Clinical Trials Market Size by Country (2018-2023)
8.4 Europe CRO in Clinical Trials Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific CRO in Clinical Trials Market Size (2018-2029)
9.2 Asia-Pacific CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific CRO in Clinical Trials Market Size by Country (2018-2023)
9.4 Asia-Pacific CRO in Clinical Trials Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America CRO in Clinical Trials Market Size (2018-2029)
10.2 Latin America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America CRO in Clinical Trials Market Size by Country (2018-2023)
10.4 Latin America CRO in Clinical Trials Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa CRO in Clinical Trials Market Size (2018-2029)
11.2 Middle East & Africa CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa CRO in Clinical Trials Market Size by Country (2018-2023)
11.4 Middle East & Africa CRO in Clinical Trials Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 Labcorp
  11.1.1 Labcorp Company Detail
  11.1.2 Labcorp Business Overview
  11.1.3 Labcorp CRO in Clinical Trials Introduction
  11.1.4 Labcorp Revenue in CRO in Clinical Trials Business (2017-2022)
  11.1.5 Labcorp Recent Development
11.2 IQVIA
  11.2.1 IQVIA Company Detail
  11.2.2 IQVIA Business Overview
  11.2.3 IQVIA CRO in Clinical Trials Introduction
  11.2.4 IQVIA Revenue in CRO in Clinical Trials Business (2017-2022)
  11.2.5 IQVIA Recent Development
11.3 Parexel
  11.3.1 Parexel Company Detail
  11.3.2 Parexel Business Overview
  11.3.3 Parexel CRO in Clinical Trials Introduction
  11.3.4 Parexel Revenue in CRO in Clinical Trials Business (2017-2022)
  11.3.5 Parexel Recent Development
11.4 Syneos Health
  11.4.1 Syneos Health Company Detail
  11.4.2 Syneos Health Business Overview
  11.4.3 Syneos Health CRO in Clinical Trials Introduction
  11.4.4 Syneos Health Revenue in CRO in Clinical Trials Business (2017-2022)
  11.4.5 Syneos Health Recent Development
11.5 PRA Health Sciences
  11.5.1 PRA Health Sciences Company Detail
  11.5.2 PRA Health Sciences Business Overview
  11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction
  11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2017-2022)
  11.5.5 PRA Health Sciences Recent Development
11.6 PPD
  11.6.1 PPD Company Detail
  11.6.2 PPD Business Overview
  11.6.3 PPD CRO in Clinical Trials Introduction
  11.6.4 PPD Revenue in CRO in Clinical Trials Business (2017-2022)
  11.6.5 PPD Recent Development
11.7 ICON
  11.7.1 ICON Company Detail
  11.7.2 ICON Business Overview
  11.7.3 ICON CRO in Clinical Trials Introduction
  11.7.4 ICON Revenue in CRO in Clinical Trials Business (2017-2022)
  11.7.5 ICON Recent Development
11.8 MedPace
  11.8.1 MedPace Company Detail
  11.8.2 MedPace Business Overview
  11.8.3 MedPace CRO in Clinical Trials Introduction
  11.8.4 MedPace Revenue in CRO in Clinical Trials Business (2017-2022)
  11.8.5 MedPace Recent Development
11.9 Wuxi AppTec
  11.9.1 Wuxi AppTec Company Detail
  11.9.2 Wuxi AppTec Business Overview
  11.9.3 Wuxi AppTec CRO in Clinical Trials Introduction
  11.9.4 Wuxi AppTec Revenue in CRO in Clinical Trials Business (2017-2022)
  11.9.5 Wuxi AppTec Recent Development

13 REPORT CONCLUSION


14 DISCLAIMER


LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by End User (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global CRO in Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global CRO in Clinical Trials Revenue Market Share by Type (2018-2023)
Table 7. Global CRO in Clinical Trials Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global CRO in Clinical Trials Revenue Market Share by Type (2024-2029)
Table 9. Global CRO in Clinical Trials Market Size by End User (2018-2023) & (US$ Million)
Table 10. Global CRO in Clinical Trials Revenue Market Share by End User (2018-2023)
Table 11. Global CRO in Clinical Trials Forecasted Market Size by End User (2024-2029) & (US$ Million)
Table 12. Global CRO in Clinical Trials Revenue Market Share by End User (2024-2029)
Table 13. Global CRO in Clinical Trials Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global CRO in Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global CRO in Clinical Trials Market Share by Region (2018-2023)
Table 16. Global CRO in Clinical Trials Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global CRO in Clinical Trials Market Share by Region (2024-2029)
Table 18. CRO in Clinical Trials Market Trends
Table 19. CRO in Clinical Trials Market Drivers
Table 20. CRO in Clinical Trials Market Challenges
Table 21. CRO in Clinical Trials Market Restraints
Table 22. Global Top CRO in Clinical Trials Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global CRO in Clinical Trials Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global CRO in Clinical Trials Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of CRO in Clinical Trials, Headquarters and Area Served
Table 26. Global CRO in Clinical Trials Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global CRO in Clinical Trials by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 45. Labcorp Company Detail
Table 46. Labcorp Business Overview
Table 47. Labcorp CRO in Clinical Trials Product
Table 48. Labcorp Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 49. Labcorp Recent Development
Table 50. IQVIA Company Detail
Table 51. IQVIA Business Overview
Table 52. IQVIA CRO in Clinical Trials Product
Table 53. IQVIA Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 54. IQVIA Recent Development
Table 55. Parexel Company Detail
Table 56. Parexel Business Overview
Table 57. Parexel CRO in Clinical Trials Product
Table 58. Parexel Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 59. Parexel Recent Development
Table 60. Syneos Health Company Detail
Table 61. Syneos Health Business Overview
Table 62. Syneos Health CRO in Clinical Trials Product
Table 63. Syneos Health Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 64. Syneos Health Recent Development
Table 65. PRA Health Sciences Company Detail
Table 66. PRA Health Sciences Business Overview
Table 67. PRA Health Sciences CRO in Clinical Trials Product
Table 68. PRA Health Sciences Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 69. PRA Health Sciences Recent Development
Table 70. PPD Company Detail
Table 71. PPD Business Overview
Table 72. PPD CRO in Clinical Trials Product
Table 73. PPD Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 74. PPD Recent Development
Table 75. ICON Company Detail
Table 76. ICON Business Overview
Table 77. ICON CRO in Clinical Trials Product
Table 78. ICON Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 79. ICON Recent Development
Table 80. MedPace Company Detail
Table 81. MedPace Business Overview
Table 82. MedPace CRO in Clinical Trials Product
Table 83. MedPace Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 84. MedPace Recent Development
Table 85. Wuxi AppTec Company Detail
Table 86. Wuxi AppTec Business Overview
Table 87. Wuxi AppTec CRO in Clinical Trials Product
Table 88. Wuxi AppTec Revenue in CRO in Clinical Trials Business (2017-2022) & (US$ Million)
Table 89. Wuxi AppTec Recent Development
Table 90. Labcorp Company Information
Table 91. Labcorp Business Overview
Table 92. Labcorp CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 93. Labcorp Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 94. Labcorp Recent Development
Table 95. IQVIA Company Information
Table 96. IQVIA Business Overview
Table 97. IQVIA CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 98. IQVIA Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 99. IQVIA Recent Development
Table 100. Parexel Company Information
Table 101. Parexel Business Overview
Table 102. Parexel CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 103. Parexel Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 104. Parexel Recent Development
Table 105. Syneos Health Company Information
Table 106. Syneos Health Business Overview
Table 107. Syneos Health CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 108. Syneos Health Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 109. Syneos Health Recent Development
Table 110. PRA Health Sciences Company Information
Table 111. PRA Health Sciences Business Overview
Table 112. PRA Health Sciences CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 113. PRA Health Sciences Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 114. PRA Health Sciences Recent Development
Table 115. PPD Company Information
Table 116. PPD Business Overview
Table 117. PPD CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 118. PPD Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 119. PPD Recent Development
Table 120. ICON Company Information
Table 121. ICON Business Overview
Table 122. ICON CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 123. ICON Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 124. ICON Recent Development
Table 125. MedPace Company Information
Table 126. MedPace Business Overview
Table 127. MedPace CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 128. MedPace Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio
Table 129. MedPace Recent Development
Table 130. Wuxi AppTec Company Information
Table 131. Wuxi AppTec Business Overview
Table 132. Wuxi AppTec CRO in Clinical Trials Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 133. Wuxi AppTec Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million) Portfolio


More Publications